 |
BioWorld-International-2006-05-17
AstraZeneca Buying CAT, Giving Valuation Of $1.3B
AstraZeneca Buying CAT, Giving Valuation Of $1.3B
LONDON - AstraZeneca plc is buying Cambridge Antibody Technology (CAT) Group plc, the UK's largest biotech, in an agreed cash deal that will cost AstraZeneca £567 million, and values CAT at £702 million (US$1.3 billion). (BioWorld International)